An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis

Hypertension Research

Volumn 25, Issue 6, 2002, Pages 875-880

  Kawamoto, Ryuichi ^a   Kohara, Katsuhiko ^b   Tabara, Yasuharu ^b   Miki, Tetsuro ^b  

^a Nomura Municipal Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ACE; Gene; Interaction; Polymorphism; Risk factor

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SULFONYLUREA; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALLELE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CAROTID ARTERY DISEASE; CIGARETTE SMOKING; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIPLE REGRESSION; PATHOGENESIS; PREDICTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

EID: 0036866329     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.875     Document Type: Article

References (33)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
2. Kitakaze M, Node K, Takashima S, Minamino T, Kuzuya T, Hori M: Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide. Hypertens Res 2000; 23: 253-259.
3. Daeman MJAP, Lanbardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456.
4. Kato H, Suzuki H, Tajima S, et al: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991; 9: 17-21.
5. Farhy RD, Ho KL, Carretero OA, Scicli AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182: 283-288.
6. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712.
7. Nakai K, Itoh C, Miura Y, et al: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-2202.
8. Ohishi M, Fujii K, Minamino T, et al: A potent genetic risk factor for restenosis. Nat Genet 1993; 5: 324-325.
9. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-2628.
10. Wu S, Hong J, Li H, et al: No correlation of polymorphism of angiotensin-converting enzyme genes with left ventricular hypertrophy in essential hypertension. Hypertens Res 2000; 23: 261-264.
11. Castellano M, Muiesan ML, Rizzoni D, et al: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno Study. Circulation 1995; 91: 2721-2724.
12. Pujia A, Motti C, Irace C, et al: Deletion polymorphism in angiotensin converting enzyme gene associated with carotid wall thickening in a healthy male population. Coron Artery Dis 1996; 98: 51-55.
13. Hosoi M, Nishizawa Y, Kogawa K, et al: Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 1996; 94: 704-707.
14. Kauma H, Paivansalo M, Savolainen MJ, et al: Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 1996; 14: 1183-1187.
15. Zannad F, Visvikis S, Gueguen R, et al: Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet 1998; 103: 183-188.
16. Arnett DK, Borecki IB, Ludwig EH, et al: Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies. Atherosclerosis 1998; 138: 111-116.
17. Sass C, Zannad F, Herbeth B, et al: Apolipoprotein E4, lipoprotein lipase C447, and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis 1998; 140: 89-95.
18. Girerd X, Hanon O, Mourad JJ, Boutouyrie P, Laurent S, Jeunemaitre X: Lack of association between renin-angiotensin system, gene polymorphisms, and wall thickness of the radial and carotid arteries. Hypertension 1998; 32: 579-583.
19. Kardia SLR: Context-dependent genetic effects in hypertension. Curr Hypertens Rep 2000; 2: 32-38.
20. Tabara T, Kohara K, Nakura J, Miki T: Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 2001; 46: 278-284.
21. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
22. Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3: 120-121.
23. Nakata Y, Katsuya T, Rakugi H, et al: Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension 1996; 27: 1205-1209.
24. Huang XH, Loimaala A, Nenonen A, et al: Relationship of angiotensin-converting enzyme gene polymorphism to carotid wall thickness in middle-aged men. J Mol Med 1999; 77: 853-858.
25. Hung J, McQuillan BM, Nidorf M, Thompson PL, Beilby JP: Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb 1999; 19: 1969-1974.
26. Mannami T, Katsuya T, Baba S, et al: Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study. Stroke 2001; 32: 1250-1256.
27. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, et al: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994; 89: 952-954.
28. Jan Danser AH, Schalekamp MADH, Bax WA, et al: ACE in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
29. Morishita R, Gibbons GH, Ellison KE, et al: Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994; 94: 978-984.
30. O'Donnell CJ, Lindpaintner K, Larson MG, et al: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 98: 1766-1772.
31. Higaki J, Baba S, Katsuya T, et al: Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men. Circulation 2000; 101: 2060-2065.
32. Kohara K, Tabara Y, Yamamoto Y, Igase M, Nakura J, Miki T: Genotype-specific association between circulating soluble cellular adhesion molecules and carotid intima-media thickness in community residents: J-SHIPP study: Shimanami Health Promoting Program. Hypertens Res 2002; 25: 31-39.
33. Iseki K, Kimura Y, Wakugami K, et al: Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000; 23: 143-149.